Mobile Phone Messaging to Improve Reproductive Health for Women Living With HIV in Kenya (Mobile WACh Empower)
Launched by UNIVERSITY OF WASHINGTON · Mar 14, 2022
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The Mobile WACh Empower trial is looking to find out if sending text messages can help improve reproductive health for women living with HIV in Kenya. The study will provide women with information and counseling about reproductive health through their mobile phones while they receive regular HIV care. This approach aims to help women make informed choices about contraception and fertility, ultimately leading to better health outcomes.
To take part in this study, women need to be between 14 and 45 years old, living with HIV, and currently receiving HIV care at the study site. They should also have regular access to a mobile phone and be able to read or understand messages in English, Kiswahili, or Luo. Participants can expect to receive helpful information through text messages over the course of the study, which will last for about two years. It's important to note that women who are currently pregnant will not be eligible for this trial.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • HIV-infected
- • Receiving HIV care at study site
- • Reproductive age (18-45; 14-17 if emancipated minors)
- • Daily access to mobile phone (own phone or shared)
- • Plan to receive HIV care at enrollment facility for 2 years
- • Speak English, Kiswahili, or Luo
- • Literate or comfortable with someone reading study SMS
- Exclusion Criteria:
- • Currently pregnant
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nairobi, , Kenya
Siaya, , Kenya
Nairobi, , Kenya
Kisumu, , Kenya
Bondo, , Kenya
Kisumu, , Kenya
Nairobi, , Kenya
Nairobi, , Kenya
Nairobi, , Kenya
Oyugis, , Kenya
Patients applied
Trial Officials
Alison Drake, PHD
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials